论文部分内容阅读
目的：观察双氢麦角毒治疗脑血管疾病的疗效。方法：脑血管疾病病人１２０例（男性８１例，女性３９例，年龄５８±ｓ８ａ），其中口服治疗组６０例，给予双氢麦角毒２．５ｍｇ，ｐｏ，ｂｉｄ；注射组６０例病人给双氢麦角毒０．３ｍｇ，ｉｍ，ｑｄ，均３０ｄ为一个疗程，作口服和注射给药临床症状改善比较。另用相似３０例为对照组，给予曲克芦丁１００ｍｇ，ｐｏ，ｂｉｄ，也是３０ｄ为一个疗程。结果：口服双氢麦角毒疗效显著优于曲克芦丁（Ｐ＜０．０１）；注射双氢麦角毒临床症状改善优于口服。结论：双氢麦角毒有改善脑血管疾病病人因脑血管循环障碍引起的脑部症状。
Objective: To observe the efficacy of dihydroergotoxi in the treatment of cerebrovascular disease. Methods: 120 patients with cerebrovascular disease (81 males and 39 females, age 58 ± s8a), 60 patients in the oral treatment group were given dihydroergotoxin 2.5mg, po, bid; 60 patients in the injection group were given double Hydrolytic horn 0.3mg, im, qd, were 30d for a course of treatment for oral administration and injection of clinical symptoms improved comparison. Another similar 30 cases for the control group, giving troxerutin 100mg, po, bid, also 30d for a course of treatment. Results: The efficacy of oral dihydroergotoxine was significantly better than that of troxerutin (P <0.01). The improvement of clinical symptoms was better than that of oral administration of dihydroergotoxel. Conclusion: Dihydroergotoxine can ameliorate cerebral symptoms in patients with cerebrovascular diseases due to cerebrovascular circulatory disorders.